The Global Vaccines Innovation and Immunology Conference (GVX Immunology 2026) will take place from September 21–23, 2026 in London, UK & Online, bringing together global experts to explore the latest advancements in vaccinology.
This
hybrid event serves as a central platform for unveiling cutting-edge
discoveries in vaccine science, development, and delivery technologies,
highlighting the critical role of vaccines in protecting global health.
🔬 Key Focus Areas
Participants
can explore a wide range of topics, including:
- Next-generation vaccine design
- Enhancing vaccine efficacy and
durability
- mRNA and viral vector vaccines
- Novel adjuvants and delivery
systems
- Strategies for equitable
vaccine distribution
- Addressing vaccine hesitancy
through communication
These
sessions provide valuable insights into how innovation is shaping the future of
healthcare.
🌐 Hybrid Experience & Global
Collaboration
With both in-person
and virtual participation, GVX 2026 ensures accessibility for a global
audience. The conference fosters collaboration among:
- Researchers
- Industry professionals
- Public health experts
- Policymakers
- Students
Attendees
can engage, network, and exchange ideas on a global scale.
📚 Publication Opportunity
The event
is supported by the Mathews Journal of Immunology & Allergy,
offering:
- DOI assignment for conference
proceedings
- Opportunity to publish
full-length research articles
- Free article processing
charges
- Peer-reviewed publication
This
provides a valuable platform for researchers to gain recognition and global
visibility.
🌍 Join the Conference
Be part of
a transformative event driving innovation in vaccine science and global health.
📅 September 21–23, 2026
📍
London, UK & Online
🔗 Explore More:
https://vaccines.miconferences.com/
No comments:
Post a Comment